{"id":"https://openalex.org/W1574460503","doi":"https://doi.org/10.1007/978-1-4615-4811-9_5","title":"Quinine Improves Results of Intensive Chemotherapy (IC) in Myelodysplastic Syndromes (MDS) Expressing P-Glycoprotein (PGP)","display_name":"Quinine Improves Results of Intensive Chemotherapy (IC) in Myelodysplastic Syndromes (MDS) Expressing P-Glycoprotein (PGP)","publication_year":1999,"publication_date":"1999-01-01","ids":{"openalex":"https://openalex.org/W1574460503","doi":"https://doi.org/10.1007/978-1-4615-4811-9_5","mag":"1574460503","pmid":"https://pubmed.ncbi.nlm.nih.gov/10500778"},"language":"en","primary_location":{"id":"doi:10.1007/978-1-4615-4811-9_5","doi":"https://doi.org/10.1007/978-1-4615-4811-9_5","is_oa":false,"landing_page_url":"https://doi.org/10.1007/978-1-4615-4811-9_5","pdf_url":null,"source":{"id":"https://openalex.org/S43790123","display_name":"Advances in experimental medicine and biology","issn_l":"0065-2598","issn":["0065-2598","2214-8019"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","ki-jl-1","medline","norway-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"book series"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Advances in Experimental Medicine and Biology","raw_type":"book-chapter"},"volume":{"id":"https://openalex.org/W1583876657","display_name":"Drug Resistance in Leukemia and Lymphoma III"},"type":"book-chapter","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5088794779","display_name":"Eric Wattel","orcid":"https://orcid.org/0000-0003-4254-1692","observed_orcids":["https://orcid.org/0000-0003-4254-1692"]},"institutions":[{"id":"https://openalex.org/I3018718406","display_name":"Centre Hospitalier Universitaire de Lille","ror":"https://ror.org/02ppyfa04","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018718406"]},{"id":"https://openalex.org/I4210138283","display_name":"Groupe Francophone des My\u00e9lodysplasies","ror":"https://ror.org/04db0ec72","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4210138283"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"E. Wattel","raw_affiliation_strings":["Service des Maladies du Sang, CHU, Lille, France","Groupe Fran\u00e7ais des My\u00e9lodysplasies (GFM) and Groupe GOELAMS, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Service des Maladies du Sang, CHU, Lille, France","institution_ids":["https://openalex.org/I3018718406"]},{"raw_affiliation_string":"Groupe Fran\u00e7ais des My\u00e9lodysplasies (GFM) and Groupe GOELAMS, France","institution_ids":["https://openalex.org/I4210138283"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023810956","display_name":"\u00c9ric Solary","orcid":"https://orcid.org/0000-0002-8629-1341","observed_orcids":["https://orcid.org/0000-0002-8629-1341"]},"institutions":[{"id":"https://openalex.org/I4210138283","display_name":"Groupe Francophone des My\u00e9lodysplasies","ror":"https://ror.org/04db0ec72","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4210138283"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"E. Solary","raw_affiliation_strings":["Groupe Fran\u00e7ais des My\u00e9lodysplasies (GFM) and Groupe GOELAMS, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Groupe Fran\u00e7ais des My\u00e9lodysplasies (GFM) and Groupe GOELAMS, France","institution_ids":["https://openalex.org/I4210138283"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014403951","display_name":"B Hecquet","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210138283","display_name":"Groupe Francophone des My\u00e9lodysplasies","ror":"https://ror.org/04db0ec72","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4210138283"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"B. Hecquet","raw_affiliation_strings":["Groupe Fran\u00e7ais des My\u00e9lodysplasies (GFM) and Groupe GOELAMS, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Groupe Fran\u00e7ais des My\u00e9lodysplasies (GFM) and Groupe GOELAMS, France","institution_ids":["https://openalex.org/I4210138283"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075950291","display_name":"Denis Caillot","orcid":"https://orcid.org/0009-0009-6985-5609","observed_orcids":["https://orcid.org/0009-0009-6985-5609"]},"institutions":[{"id":"https://openalex.org/I4210138283","display_name":"Groupe Francophone des My\u00e9lodysplasies","ror":"https://ror.org/04db0ec72","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4210138283"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"D. Caillot","raw_affiliation_strings":["Groupe Fran\u00e7ais des My\u00e9lodysplasies (GFM) and Groupe GOELAMS, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Groupe Fran\u00e7ais des My\u00e9lodysplasies (GFM) and Groupe GOELAMS, France","institution_ids":["https://openalex.org/I4210138283"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037324033","display_name":"Norbert Ifrah","orcid":"https://orcid.org/0000-0003-3063-850X","observed_orcids":["https://orcid.org/0000-0003-3063-850X"]},"institutions":[{"id":"https://openalex.org/I4210138283","display_name":"Groupe Francophone des My\u00e9lodysplasies","ror":"https://ror.org/04db0ec72","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4210138283"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"N. Ifrah","raw_affiliation_strings":["Groupe Fran\u00e7ais des My\u00e9lodysplasies (GFM) and Groupe GOELAMS, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Groupe Fran\u00e7ais des My\u00e9lodysplasies (GFM) and Groupe GOELAMS, France","institution_ids":["https://openalex.org/I4210138283"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110493735","display_name":"A. Brion","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210138283","display_name":"Groupe Francophone des My\u00e9lodysplasies","ror":"https://ror.org/04db0ec72","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4210138283"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"A. Brion","raw_affiliation_strings":["Groupe Fran\u00e7ais des My\u00e9lodysplasies (GFM) and Groupe GOELAMS, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Groupe Fran\u00e7ais des My\u00e9lodysplasies (GFM) and Groupe GOELAMS, France","institution_ids":["https://openalex.org/I4210138283"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034473496","display_name":"Noel Jean Milpied","orcid":"https://orcid.org/0000-0002-5177-014X","observed_orcids":["https://orcid.org/0000-0002-5177-014X"]},"institutions":[{"id":"https://openalex.org/I4210138283","display_name":"Groupe Francophone des My\u00e9lodysplasies","ror":"https://ror.org/04db0ec72","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4210138283"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"N. Milpied","raw_affiliation_strings":["Groupe Fran\u00e7ais des My\u00e9lodysplasies (GFM) and Groupe GOELAMS, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Groupe Fran\u00e7ais des My\u00e9lodysplasies (GFM) and Groupe GOELAMS, France","institution_ids":["https://openalex.org/I4210138283"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085665866","display_name":"Maud Janvier","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210138283","display_name":"Groupe Francophone des My\u00e9lodysplasies","ror":"https://ror.org/04db0ec72","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4210138283"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"M. Janvier","raw_affiliation_strings":["Groupe Fran\u00e7ais des My\u00e9lodysplasies (GFM) and Groupe GOELAMS, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Groupe Fran\u00e7ais des My\u00e9lodysplasies (GFM) and Groupe GOELAMS, France","institution_ids":["https://openalex.org/I4210138283"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112296198","display_name":"Agn\u00e8s Guerci\u2010Bresler","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210138283","display_name":"Groupe Francophone des My\u00e9lodysplasies","ror":"https://ror.org/04db0ec72","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4210138283"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"A. Guerci","raw_affiliation_strings":["Groupe Fran\u00e7ais des My\u00e9lodysplasies (GFM) and Groupe GOELAMS, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Groupe Fran\u00e7ais des My\u00e9lodysplasies (GFM) and Groupe GOELAMS, France","institution_ids":["https://openalex.org/I4210138283"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070690914","display_name":"Henri Rochant","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210138283","display_name":"Groupe Francophone des My\u00e9lodysplasies","ror":"https://ror.org/04db0ec72","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4210138283"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"H. Rochant","raw_affiliation_strings":["Groupe Fran\u00e7ais des My\u00e9lodysplasies (GFM) and Groupe GOELAMS, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Groupe Fran\u00e7ais des My\u00e9lodysplasies (GFM) and Groupe GOELAMS, France","institution_ids":["https://openalex.org/I4210138283"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034726747","display_name":"Catherine Cordonnier","orcid":"https://orcid.org/0000-0002-3216-5470","observed_orcids":["https://orcid.org/0000-0002-3216-5470"]},"institutions":[{"id":"https://openalex.org/I4210138283","display_name":"Groupe Francophone des My\u00e9lodysplasies","ror":"https://ror.org/04db0ec72","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4210138283"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"C. Cordonnier","raw_affiliation_strings":["Groupe Fran\u00e7ais des My\u00e9lodysplasies (GFM) and Groupe GOELAMS, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Groupe Fran\u00e7ais des My\u00e9lodysplasies (GFM) and Groupe GOELAMS, France","institution_ids":["https://openalex.org/I4210138283"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113656248","display_name":"Fran\u00e7ois Dreyfus","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210138283","display_name":"Groupe Francophone des My\u00e9lodysplasies","ror":"https://ror.org/04db0ec72","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4210138283"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"F. Dreyfus","raw_affiliation_strings":["Groupe Fran\u00e7ais des My\u00e9lodysplasies (GFM) and Groupe GOELAMS, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Groupe Fran\u00e7ais des My\u00e9lodysplasies (GFM) and Groupe GOELAMS, France","institution_ids":["https://openalex.org/I4210138283"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038643703","display_name":"Agnes Veil","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210138283","display_name":"Groupe Francophone des My\u00e9lodysplasies","ror":"https://ror.org/04db0ec72","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4210138283"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"A. Veil","raw_affiliation_strings":["Groupe Fran\u00e7ais des My\u00e9lodysplasies (GFM) and Groupe GOELAMS, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Groupe Fran\u00e7ais des My\u00e9lodysplasies (GFM) and Groupe GOELAMS, France","institution_ids":["https://openalex.org/I4210138283"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090713105","display_name":"L. Hoang-Ngoc","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210138283","display_name":"Groupe Francophone des My\u00e9lodysplasies","ror":"https://ror.org/04db0ec72","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4210138283"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"L. Hoang-Ngoc","raw_affiliation_strings":["Groupe Fran\u00e7ais des My\u00e9lodysplasies (GFM) and Groupe GOELAMS, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Groupe Fran\u00e7ais des My\u00e9lodysplasies (GFM) and Groupe GOELAMS, France","institution_ids":["https://openalex.org/I4210138283"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110228656","display_name":"Anne\u2010Marie Stoppa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210138283","display_name":"Groupe Francophone des My\u00e9lodysplasies","ror":"https://ror.org/04db0ec72","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4210138283"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"A. M. Stoppa","raw_affiliation_strings":["Groupe Fran\u00e7ais des My\u00e9lodysplasies (GFM) and Groupe GOELAMS, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Groupe Fran\u00e7ais des My\u00e9lodysplasies (GFM) and Groupe GOELAMS, France","institution_ids":["https://openalex.org/I4210138283"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024926257","display_name":"Nicole Gratecos","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210138283","display_name":"Groupe Francophone des My\u00e9lodysplasies","ror":"https://ror.org/04db0ec72","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4210138283"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"N. Gratecos","raw_affiliation_strings":["Groupe Fran\u00e7ais des My\u00e9lodysplasies (GFM) and Groupe GOELAMS, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Groupe Fran\u00e7ais des My\u00e9lodysplasies (GFM) and Groupe GOELAMS, France","institution_ids":["https://openalex.org/I4210138283"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052935862","display_name":"Alain Sadoun","orcid":"https://orcid.org/0009-0007-7721-6714","observed_orcids":["https://orcid.org/0009-0007-7721-6714"]},"institutions":[{"id":"https://openalex.org/I4210138283","display_name":"Groupe Francophone des My\u00e9lodysplasies","ror":"https://ror.org/04db0ec72","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4210138283"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"A. Sadoun","raw_affiliation_strings":["Groupe Fran\u00e7ais des My\u00e9lodysplasies (GFM) and Groupe GOELAMS, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Groupe Fran\u00e7ais des My\u00e9lodysplasies (GFM) and Groupe GOELAMS, France","institution_ids":["https://openalex.org/I4210138283"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003078312","display_name":"Herv\u00e9 Tilly","orcid":"https://orcid.org/0000-0001-7022-5246","observed_orcids":["https://orcid.org/0000-0001-7022-5246"]},"institutions":[{"id":"https://openalex.org/I4210138283","display_name":"Groupe Francophone des My\u00e9lodysplasies","ror":"https://ror.org/04db0ec72","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4210138283"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"H. Tilly","raw_affiliation_strings":["Groupe Fran\u00e7ais des My\u00e9lodysplasies (GFM) and Groupe GOELAMS, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Groupe Fran\u00e7ais des My\u00e9lodysplasies (GFM) and Groupe GOELAMS, France","institution_ids":["https://openalex.org/I4210138283"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103061699","display_name":"Pauline Brice","orcid":"https://orcid.org/0000-0002-9227-277X","observed_orcids":["https://orcid.org/0000-0002-9227-277X"]},"institutions":[{"id":"https://openalex.org/I4210138283","display_name":"Groupe Francophone des My\u00e9lodysplasies","ror":"https://ror.org/04db0ec72","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4210138283"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"P. Brice","raw_affiliation_strings":["Groupe Fran\u00e7ais des My\u00e9lodysplasies (GFM) and Groupe GOELAMS, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Groupe Fran\u00e7ais des My\u00e9lodysplasies (GFM) and Groupe GOELAMS, France","institution_ids":["https://openalex.org/I4210138283"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015832963","display_name":"Bruno Lioure","orcid":"https://orcid.org/0000-0003-0897-3416","observed_orcids":["https://orcid.org/0000-0003-0897-3416"]},"institutions":[{"id":"https://openalex.org/I4210138283","display_name":"Groupe Francophone des My\u00e9lodysplasies","ror":"https://ror.org/04db0ec72","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4210138283"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"B. Lioure","raw_affiliation_strings":["Groupe Fran\u00e7ais des My\u00e9lodysplasies (GFM) and Groupe GOELAMS, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Groupe Fran\u00e7ais des My\u00e9lodysplasies (GFM) and Groupe GOELAMS, France","institution_ids":["https://openalex.org/I4210138283"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032008939","display_name":"B Desablens","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210138283","display_name":"Groupe Francophone des My\u00e9lodysplasies","ror":"https://ror.org/04db0ec72","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4210138283"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"B. Desablens","raw_affiliation_strings":["Groupe Fran\u00e7ais des My\u00e9lodysplasies (GFM) and Groupe GOELAMS, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Groupe Fran\u00e7ais des My\u00e9lodysplasies (GFM) and Groupe GOELAMS, France","institution_ids":["https://openalex.org/I4210138283"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031879677","display_name":"Bernard Pignon","orcid":"https://orcid.org/0000-0002-4691-708X","observed_orcids":["https://orcid.org/0000-0002-4691-708X"]},"institutions":[{"id":"https://openalex.org/I4210138283","display_name":"Groupe Francophone des My\u00e9lodysplasies","ror":"https://ror.org/04db0ec72","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4210138283"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"B. Pignon","raw_affiliation_strings":["Groupe Fran\u00e7ais des My\u00e9lodysplasies (GFM) and Groupe GOELAMS, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Groupe Fran\u00e7ais des My\u00e9lodysplasies (GFM) and Groupe GOELAMS, France","institution_ids":["https://openalex.org/I4210138283"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025930732","display_name":"JF Abgrall","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210138283","display_name":"Groupe Francophone des My\u00e9lodysplasies","ror":"https://ror.org/04db0ec72","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4210138283"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"J. P. Abgrall","raw_affiliation_strings":["Groupe Fran\u00e7ais des My\u00e9lodysplasies (GFM) and Groupe GOELAMS, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Groupe Fran\u00e7ais des My\u00e9lodysplasies (GFM) and Groupe GOELAMS, France","institution_ids":["https://openalex.org/I4210138283"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017512905","display_name":"Michel Leporrier","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210138283","display_name":"Groupe Francophone des My\u00e9lodysplasies","ror":"https://ror.org/04db0ec72","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4210138283"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"M. Leporrier","raw_affiliation_strings":["Groupe Fran\u00e7ais des My\u00e9lodysplasies (GFM) and Groupe GOELAMS, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Groupe Fran\u00e7ais des My\u00e9lodysplasies (GFM) and Groupe GOELAMS, France","institution_ids":["https://openalex.org/I4210138283"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007550143","display_name":"Brigitte Dupriez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210138283","display_name":"Groupe Francophone des My\u00e9lodysplasies","ror":"https://ror.org/04db0ec72","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4210138283"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"B. Dupriez","raw_affiliation_strings":["Groupe Fran\u00e7ais des My\u00e9lodysplasies (GFM) and Groupe GOELAMS, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Groupe Fran\u00e7ais des My\u00e9lodysplasies (GFM) and Groupe GOELAMS, France","institution_ids":["https://openalex.org/I4210138283"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110494736","display_name":"Denis Guyotat","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210138283","display_name":"Groupe Francophone des My\u00e9lodysplasies","ror":"https://ror.org/04db0ec72","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4210138283"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"D. Guyotat","raw_affiliation_strings":["Groupe Fran\u00e7ais des My\u00e9lodysplasies (GFM) and Groupe GOELAMS, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Groupe Fran\u00e7ais des My\u00e9lodysplasies (GFM) and Groupe GOELAMS, France","institution_ids":["https://openalex.org/I4210138283"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059980892","display_name":"Pascale Lepelley","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210138283","display_name":"Groupe Francophone des My\u00e9lodysplasies","ror":"https://ror.org/04db0ec72","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4210138283"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"P. Lepelley","raw_affiliation_strings":["Groupe Fran\u00e7ais des My\u00e9lodysplasies (GFM) and Groupe GOELAMS, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Groupe Fran\u00e7ais des My\u00e9lodysplasies (GFM) and Groupe GOELAMS, France","institution_ids":["https://openalex.org/I4210138283"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5014838075","display_name":"Pierre Fenaux","orcid":"https://orcid.org/0000-0002-0468-3553","observed_orcids":["https://orcid.org/0000-0002-0468-3553"]},"institutions":[{"id":"https://openalex.org/I3018718406","display_name":"Centre Hospitalier Universitaire de Lille","ror":"https://ror.org/02ppyfa04","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018718406"]},{"id":"https://openalex.org/I4210138283","display_name":"Groupe Francophone des My\u00e9lodysplasies","ror":"https://ror.org/04db0ec72","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4210138283"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"P. Fenaux","raw_affiliation_strings":["Groupe Fran\u00e7ais des My\u00e9lodysplasies (GFM) and Groupe GOELAMS, France","Service des Maladies du Sang, CHU, 1 place de Verdun, 59037, Lille, France","Service des Maladies du Sang, CHU, Lille, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Groupe Fran\u00e7ais des My\u00e9lodysplasies (GFM) and Groupe GOELAMS, France","institution_ids":["https://openalex.org/I4210138283"]},{"raw_affiliation_string":"Service des Maladies du Sang, CHU, 1 place de Verdun, 59037, Lille, France","institution_ids":["https://openalex.org/I3018718406"]},{"raw_affiliation_string":"Service des Maladies du Sang, CHU, Lille, France","institution_ids":["https://openalex.org/I3018718406"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.8329,"has_fulltext":false,"cited_by_count":34,"citation_normalized_percentile":{"value":0.90070922,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"457","issue":null,"first_page":"35","last_page":"46"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.6791999936103821,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.6791999936103821,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.2992999851703644,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.002899999963119626,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/quinine","display_name":"quinine","score":1.0},{"id":"https://openalex.org/keywords/myelodysplastic-syndrome","display_name":"myelodysplastic syndrome","score":0.9950000047683716},{"id":"https://openalex.org/keywords/p-glycoprotein","display_name":"P-glycoprotein","score":0.8960000276565552},{"id":"https://openalex.org/keywords/multidrug-resistance","display_name":"multidrug resistance","score":0.9559999704360962},{"id":"https://openalex.org/keywords/intensive-chemotherapy","display_name":"intensive chemotherapy","score":0.8820000290870667},{"id":"https://openalex.org/keywords/mitoxantrone","display_name":"mitoxantrone","score":0.9739999771118164},{"id":"https://openalex.org/keywords/cytarabine","display_name":"cytarabine","score":0.9959999918937683},{"id":"https://openalex.org/keywords/complete-remission","display_name":"complete remission","score":0.8109999895095825},{"id":"https://openalex.org/keywords/survival","display_name":"survival","score":0.9490000009536743},{"id":"https://openalex.org/keywords/reversal-of-drug-resistance","display_name":"drug resistance reversal","score":0.5440000295639038},{"id":"https://openalex.org/keywords/mucositis","display_name":"mucositis","score":0.7080000042915344}],"concepts":[{"id":"https://openalex.org/C2777617192","wikidata":"https://www.wikidata.org/wiki/Q189522","display_name":"Quinine","level":3,"score":0.9728920459747314},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8167693018913269},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.7565053701400757},{"id":"https://openalex.org/C2780923524","wikidata":"https://www.wikidata.org/wiki/Q239426","display_name":"Mitoxantrone","level":3,"score":0.6952038407325745},{"id":"https://openalex.org/C2778496288","wikidata":"https://www.wikidata.org/wiki/Q6931269","display_name":"Mucositis","level":3,"score":0.6830527186393738},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5688046216964722},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5308479070663452},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.5194501280784607},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.1209995448589325},{"id":"https://openalex.org/C2778048844","wikidata":"https://www.wikidata.org/wiki/Q12156","display_name":"Malaria","level":2,"score":0.11374285817146301}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000754","descriptor_name":"Anemia, Refractory, with Excess of Blasts","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D000754","descriptor_name":"Anemia, Refractory, with Excess of Blasts","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D000754","descriptor_name":"Anemia, Refractory, with Excess of Blasts","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002869","descriptor_name":"Chromosome Aberrations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002869","descriptor_name":"Chromosome Aberrations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002869","descriptor_name":"Chromosome Aberrations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003561","descriptor_name":"Cytarabine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003561","descriptor_name":"Cytarabine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003561","descriptor_name":"Cytarabine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007621","descriptor_name":"Karyotyping","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007621","descriptor_name":"Karyotyping","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007621","descriptor_name":"Karyotyping","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008942","descriptor_name":"Mitoxantrone","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D008942","descriptor_name":"Mitoxantrone","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D008942","descriptor_name":"Mitoxantrone","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D009190","descriptor_name":"Myelodysplastic Syndromes","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009190","descriptor_name":"Myelodysplastic Syndromes","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009190","descriptor_name":"Myelodysplastic Syndromes","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009190","descriptor_name":"Myelodysplastic Syndromes","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D009190","descriptor_name":"Myelodysplastic Syndromes","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D009190","descriptor_name":"Myelodysplastic Syndromes","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D009190","descriptor_name":"Myelodysplastic Syndromes","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D009190","descriptor_name":"Myelodysplastic Syndromes","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D009190","descriptor_name":"Myelodysplastic Syndromes","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D010641","descriptor_name":"Phenotype","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010641","descriptor_name":"Phenotype","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010641","descriptor_name":"Phenotype","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011803","descriptor_name":"Quinine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011803","descriptor_name":"Quinine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011803","descriptor_name":"Quinine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D012074","descriptor_name":"Remission Induction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012074","descriptor_name":"Remission Induction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012074","descriptor_name":"Remission Induction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015470","descriptor_name":"Leukemia, Myeloid, Acute","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D015470","descriptor_name":"Leukemia, Myeloid, Acute","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D015470","descriptor_name":"Leukemia, Myeloid, Acute","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D016019","descriptor_name":"Survival Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016019","descriptor_name":"Survival Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016019","descriptor_name":"Survival Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019450","descriptor_name":"Genes, MDR","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D019450","descriptor_name":"Genes, MDR","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D019450","descriptor_name":"Genes, MDR","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D020168","descriptor_name":"ATP Binding Cassette Transporter, Subfamily B, Member 1","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D020168","descriptor_name":"ATP Binding Cassette Transporter, Subfamily B, Member 1","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D020168","descriptor_name":"ATP Binding Cassette Transporter, Subfamily B, Member 1","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1007/978-1-4615-4811-9_5","doi":"https://doi.org/10.1007/978-1-4615-4811-9_5","is_oa":false,"landing_page_url":"https://doi.org/10.1007/978-1-4615-4811-9_5","pdf_url":null,"source":{"id":"https://openalex.org/S43790123","display_name":"Advances in experimental medicine and biology","issn_l":"0065-2598","issn":["0065-2598","2214-8019"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","ki-jl-1","medline","norway-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"book series"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Advances in Experimental Medicine and Biology","raw_type":"book-chapter"},{"id":"pmid:10500778","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10500778","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Advances in experimental medicine and biology","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"sustainable_development_goals_aurora":[{"display_name":"Zero hunger","id":"https://metadata.un.org/sdg/2","score":0.47999998927116394}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":51,"referenced_works":["https://openalex.org/W24843560","https://openalex.org/W29902550","https://openalex.org/W140845169","https://openalex.org/W165015714","https://openalex.org/W199216166","https://openalex.org/W1015644809","https://openalex.org/W1487506158","https://openalex.org/W1555752669","https://openalex.org/W1591450638","https://openalex.org/W1723032639","https://openalex.org/W1776168062","https://openalex.org/W1953437908","https://openalex.org/W1967425020","https://openalex.org/W1967960858","https://openalex.org/W1974345734","https://openalex.org/W1974763327","https://openalex.org/W1974950160","https://openalex.org/W1976737212","https://openalex.org/W1978459171","https://openalex.org/W1996735384","https://openalex.org/W1997595501","https://openalex.org/W2001030646","https://openalex.org/W2014944677","https://openalex.org/W2019044456","https://openalex.org/W2019356314","https://openalex.org/W2029662992","https://openalex.org/W2031186545","https://openalex.org/W2035523033","https://openalex.org/W2043201907","https://openalex.org/W2057064455","https://openalex.org/W2057160833","https://openalex.org/W2068928083","https://openalex.org/W2071287509","https://openalex.org/W2071748082","https://openalex.org/W2071982773","https://openalex.org/W2154398777","https://openalex.org/W2159512566","https://openalex.org/W2165846604","https://openalex.org/W2198835790","https://openalex.org/W2225322761","https://openalex.org/W2228456847","https://openalex.org/W2253853328","https://openalex.org/W2276606450","https://openalex.org/W2322652491","https://openalex.org/W2335886634","https://openalex.org/W2396471394","https://openalex.org/W2400293136","https://openalex.org/W2416083307","https://openalex.org/W2416220740","https://openalex.org/W2467345388","https://openalex.org/W2469926171"],"related_works":["https://openalex.org/W4389485761","https://openalex.org/W2090970329","https://openalex.org/W2092270052","https://openalex.org/W2254488496","https://openalex.org/W139966500","https://openalex.org/W2936650130","https://openalex.org/W2316222817","https://openalex.org/W91738296","https://openalex.org/W2997164716","https://openalex.org/W3025392928"],"abstract_inverted_index":null,"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2016-06-24T00:00:00"}